Gulf Pharmaceutical Industries
- 1.240 AED
- -0.010
- -0.80%
Gulf Pharmaceutical Industries Stock Overview
View Company ProfileStock Summary
| Last Price (AED) | 1.240 |
| Prev. Close | 1.250 |
| Day Range | 1.240 - 1.270 |
| 52WK range | |
| Turnover (M AED) | 1.235 |
| Volume (M) | 0.988 |
| Number of Trades | 94 |
| Market Cap (M AED) | 1,444.035 |
| Change in Market Cap (M AED) | |
| VWAP (AED) | 1.249 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M AED) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
Julphar turns into profitability in H1-25 backed by...
Abu Dhabi - Mubasher: Gulf Pharmaceutical Industries (Julphar) swung to profitability at AED 158.20 million in the first half (H1) of 2025, against net...
Julphar’s drives portfolio progress in MENA with 14%...
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) recorded sales valued at AED 1.30 billion in the first nine months (9M) of 2024,...
Julphar sees lower net losses in H1-24; revenues up...
Abu Dhabi – Mubasher: The net losses of Gulf Pharmaceutical Industries (Julphar) retreated to AED 2.40 million in the first half (H1)...
Julphar turns profitable in Q1-24; accumulated losses...
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) logged net profits attributable to the owners amounting to AED 1.90...
Julphar’s 2023 accumulated losses hit 30% of capital;...
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) registered accumulated losses valued at AED 346.70 million as of 31...
